Skip to main content

Is My Product Recalled?

Food Recalls Medication Recalls Baby Products Pet Products Toys Electronics Household Vehicles Medical Devices Other

Scan How It Works Saved Get Alerts

Menu

Search All Recalls Latest Recalls Scan Barcode Get Alerts

Categories

Food Recalls Medication Recalls Baby Products Pet Products Toys Electronics Household Vehicles Medical Devices Other

Resources

How Recalls Work FAQ Recall Classifications Statistics & Trends About

Your Recalls

Loading...

Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

Home
/
Brands
/
Bryant Ranch Prepack, Inc. dba BRP Pharmaceuticals

Bryant Ranch Prepack, Inc. dba BRP Pharmaceuticals Recalls

All product recalls associated with Bryant Ranch Prepack, Inc. dba BRP Pharmaceuticals.

Get alerts for this brand

Recall Summary

Total Recalls

11

Past Year

0

Class I (Serious)

2

Most Recent

Oct 2021

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 1–11 of 11 recalls

Methocarbamol Tablets (BRP) – labeling error (2021)

Labeling: Label Error on Declared Strength; Bottles labeled as Methocarbamol 500 mg Tablets actually contain Methocarbamol 750 mg Tablets

FDAOct 12, 2021Nationwide• Bryant Ranch Prepack, Inc. dba BRP Pharmaceuticals

Butalbital APAP Caf Tablets (Bryant Ranch) – Incomplete Labeling (2021)

Labeling: Not Elsewhere Classified: the controlled substance classification "CIII" is missing on the label

FDASep 28, 2021Nationwide• Bryant Ranch Prepack, Inc. dba BRP Pharmaceuticals

Spironolactone Tablets (Bryant Ranch) – Label Mix-Up (2021)

Labeling: Label Mix-Up - Prepackaged bottles labeled spironolactone 25 mg may contain spironolactone 50 mg tablets.

Class IHigh

FDAJan 27, 2021Nationwide• Bryant Ranch Prepack, Inc. dba BRP Pharmaceuticals

Spironolactone Tablets (Bryant Ranch) – Label Mix-Up (2021)

Labeling: Label Mix-Up - Prepackaged bottles labeled spironolactone 50 mg may contain spironolactone 25 mg tablets.

Class IIModerate

FDAJan 27, 2021Nationwide• Bryant Ranch Prepack, Inc. dba BRP Pharmaceuticals

Ofloxacin Ophthalmic Solution (PACK) – Defective Container (2013)

Defective Container: Stability samples of both products were noted to have some white solid product residue, identified as dried active ingredients along with the preservative, on the exterior of the bottles.

FDASep 9, 2013Nationwide• PACK Pharmaceuticals, LLC

Timolol Maleate Ophthalmic Solution (PACK) – Defective Container (2013)

Defective Container: Stability samples of both products were noted to have some white solid product residue, identified as dried active ingredients along with the preservative, on the exterior of the bottles.

FDASep 9, 2013Nationwide• PACK Pharmaceuticals, LLC

Timolol Maleate Ophthalmic Solution (PACK) – Defective Container (2013)

Defective Container: Stability samples of both products were noted to have some white solid product residue, identified as dried active ingredients along with the preservative, on the exterior of the bottles.

FDASep 9, 2013Nationwide• PACK Pharmaceuticals, LLC

Timolol Maleate Ophthalmic Solution (PACK) – Defective Container (2013)

Defective Container: Stability samples of both products were noted to have some white solid product residue, identified as dried active ingredients along with the preservative, on the exterior of the bottles.

FDASep 9, 2013Nationwide• PACK Pharmaceuticals, LLC

Timolol Maleate Ophthalmic Solution (PACK) – Defective Container (2013)

Defective Container: Stability samples of both products were noted to have some white solid product residue, identified as dried active ingredients along with the preservative, on the exterior of the bottles.

FDASep 9, 2013Nationwide• PACK Pharmaceuticals, LLC

Ofloxacin Ophthalmic Solution (PACK) – Defective Container (2013)

Defective Container: Stability samples of both products were noted to have some white solid product residue, identified as dried active ingredients along with the preservative, on the exterior of the bottles.

FDASep 9, 2013Nationwide• PACK Pharmaceuticals, LLC

Ciprofloxacin Tablets (Pack Pharmaceuticals) – missing label (2012)

Labeling Illegible: Missing Label; The voluntary recall of the aforementioned batch of product is being initiated due to two bottles missing container labels.

FDAMar 9, 2012Nationwide• Pack Pharmaceuticals